Organon & Co. (OGN) Earnings History
Earnings Pressure8 years of earnings data (2018–2025) · 5-year EPS trend is negative
Loading earnings history...
Organon & Co. (OGN) Earnings Overview
As of June 29, 2026, Organon & Co. (OGN) reported trailing twelve-month net income of $246M, reflecting -78.4% year-over-year growth. The company earned $0.94 per diluted share over the past four quarters, with a net profit margin of 3.0%.
Looking at the long-term picture, OGN's 5-year EPS compound annual growth rate (CAGR) stands at -39.0%, signaling declining earnings. The company achieved its highest annual net income of $3.22B in fiscal 2019.
Organon & Co. maintains positive profitability with a gross margin of 54.1%, operating margin of 20.7%, and net margin of 3.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including PFE ($7.49B net income, 12.4% margin), VTRS (-$296M net income, -24.6% margin), ABBV ($3.64B net income, 6.9% margin), OGN has room to improve margins relative to the peer group. Compare OGN vs PFE →
OGN Earnings vs Peers
Earnings metrics vs comparable public companies
OGN Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $187M | -78.4% | $1.28B | $0.72 | 3.0% | 20.7% |
| 2024 | $864M | -15.5% | $1.49B | $3.33 | 13.5% | 23.2% |
| 2023 | $1.02B | +11.6% | $1.33B | $3.99 | 16.3% | 21.2% |
| 2022 | $917M | -32.1% | $1.71B | $3.59 | 14.9% | 27.6% |
| 2021 | $1.35B | -37.5% | $1.92B | $5.33 | 21.4% | 30.4% |
| 2020 | $2.16B | -32.9% | $2.85B | $8.52 | 33.1% | 43.6% |
| 2019 | $3.22B | +49.5% | $3.85B | $12.71 | 41.4% | 49.5% |
| 2018 | $2.15B | - | $2.71B | $8.51 | 22.0% | 27.7% |
Download Data
Export OGN earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
OGN — Frequently Asked Questions
Quick answers to the most common questions about buying OGN stock.
What is OGN earnings per share (EPS)?
OGN trailing twelve-month (TTM) diluted EPS is $0.94, reflecting -78.4% year-over-year growth. The 5-year EPS CAGR is -39.0%. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Organon & Co.'s net income?
Organon & Co. (OGN) trailing twelve-month net income is $246M as of 2025. Earnings declined -78.4% year-over-year. Organon & Co. has been profitable for 8 consecutive years.
Is OGN profitable?
Yes, OGN is profitable with a TTM net income of $246M and a net profit margin of +3.0%. Organon & Co. has generated profits for 8 consecutive years.
What is OGN's earnings growth rate?
OGN compound annual EPS growth rates (CAGR): 1-Year: -78.4%, 3-Year: -41.5%, 5-Year: -39.0%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are OGN's profit margins?
Organon & Co. net profit margin is +3.0%, operating margin is +20.7%, and gross margin is +54.1%. Below-average margins reflect competitive or cost pressures. Return on Equity is +30.6%.
Is OGN growing earnings?
OGN earnings are declining — EPS fell -78.4% year-over-year. TTM net income dropped to $246M. This contrasts with the 5-year CAGR of -39.0%.
What was OGN's best earnings year?
Organon & Co.'s highest annual net income on record is $3.2B, achieved in fiscal year 2019. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were OGN's earnings last quarter?
OGN's most recent reported quarter was Q1 2026. Net income was $146M with diluted EPS of $0.55. For a full breakdown of all quarters, see the quarterly earnings table on this page.